Paul Dent

Active 1990–2024

160
Papers
23,965
Citations
97
h-index
158
i10-index

Citations

Citations per year for Paul Dent1973: 1 citations1981: 1 citations1991: 14 citations1992: 31 citations1993: 96 citations1994: 162 citations1995: 185 citations1996: 148 citations1997: 135 citations1998: 119 citations1999: 175 citations2000: 167 citations2001: 206 citations2002: 257 citations2003: 323 citations2004: 343 citations2005: 283 citations2006: 285 citations2007: 283 citations2008: 255 citations2009: 269 citations2010: 305 citations2011: 303 citations2012: 226 citations2013: 223 citations2014: 250 citations2015: 179 citations2016: 144 citations2017: 143 citations2018: 140 citations2019: 513 citations2020: 473 citations2021: 489 citations2022: 302 citations2023: 194 citations2024: 282 citations2025: 137 citations2026: 2 citations1974–1980: no citations, so these years are not shown1982–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,981 citing papers, 36.6% of this breakdownChina: 971 citing papers, 11.9% of this breakdownUnited Kingdom: 435 citing papers, 5.3% of this breakdownGermany: 413 citing papers, 5.1% of this breakdownItaly: 288 citing papers, 3.5% of this breakdownJapan: 271 citing papers, 3.3% of this breakdownFrance: 266 citing papers, 3.3% of this breakdownCanada: 225 citing papers, 2.8% of this breakdownIndia: 197 citing papers, 2.4% of this breakdownSouth Korea: 162 citing papers, 2% of this breakdownSpain: 160 citing papers, 2% of this breakdownAustralia: 155 citing papers, 1.9% of this breakdown
0%36.6%Other 19.9%

Fields

  • Biochemistry, Genetics and Molecular Biology51%
  • Medicine39.5%
  • Immunology and Microbiology2.8%
  • Neuroscience1.4%
  • Computer Science1.2%
  • Agricultural and Biological Sciences0.8%
  • Other3.3%

Topics

  • Protein Kinase Regulation and GTPase Signaling3.6%
  • Melanoma and MAPK Pathways2.8%
  • Cell death mechanisms and regulation2.8%
  • Autophagy in Disease and Therapy2.7%
  • Drug Transport and Resistance Mechanisms2.5%
  • PI3K/AKT/mTOR signaling in cancer2%
  • Other83.6%

Coauthors

All papers

Open in search
  1. Bile acids as regulatory molecules

    Authors: , , , , , - Journal of Lipid Research 2009 cited by 693

  2. Conjugated Bile Acids Activate the Sphingosine–1–Phosphate Receptor 2 in Primary Rodent Hepatocytes

    Authors: , , , , , , , , , , , , , , , - Hepatology 2011 cited by 316

  3. Targeting the Bcl-2 family for cancer therapy

    Authors: , , , , , , , , , , , - Expert Opinion on Therapeutic Targets 2012 cited by 267

  4. Autophagy

    Authors: , , , , , , , , , , , , - Advances in cancer research 2013 cited by 221

  5. Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727

    Authors: , , , , , , , , , , , , , , - Journal of Biological Chemistry 2013 cited by 182

  6. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib

    Authors: , , - Seminars in Cancer Biology 2019 cited by 83

  7. MAPK pathways in radiation responses

    Authors: , , , , - Oncogene 2003 cited by 603

  8. The role of cell signalling in the crosstalk between autophagy and apoptosis

    Authors: , , , , - Cellular Signalling 2013 cited by 341

  9. HDAC inhibitors enhance the immunotherapy response of melanoma cells

    Authors: , , , , - Oncotarget 2017 cited by 136

  10. The Kinase Inhibitor Sorafenib Induces Cell Death through a Process Involving Induction of Endoplasmic Reticulum Stress

    Authors: , , , , , , - Molecular and Cellular Biology 2007 cited by 250

  11. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 161

  12. (Curcumin+sildenafil) enhances the efficacy of 5FU and anti‐PD1 therapies in vivo

    Authors: , , , , - Journal of Cellular Physiology 2020 cited by 44

  13. Radiation-induced cell signaling: inside-out and outside-in

    Authors: , , , , , , - Molecular Cancer Therapeutics 2007 cited by 327

  14. Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells

    Authors: , , , , , , , , - Oncogene 2019 cited by 85

  15. Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery Approach

    Authors: , , , , , , , , , , , , , , - Molecular Therapy 2009 cited by 81

  16. Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancer

    Authors: - Expert Opinion on Investigational Drugs 2019 cited by 59

  17. Alteration of Ceramide Synthase 6/C16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network

    Authors: , , , , , , , , - Journal of Biological Chemistry 2011 cited by 135

  18. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes

    Authors: , , , , , , , - Hepatology 2004 cited by 130

  19. Crosstalk between ERK, AKT, and cell survival

    Authors: - Cancer Biology & Therapy 2014 cited by 97

  20. Deoxycholic Acid (DCA) Causes Ligand-independent Activation of Epidermal Growth Factor Receptor (EGFR) and FAS Receptor in Primary Hepatocytes: Inhibition of EGFR/Mitogen-activated Protein Kinase-Signaling Module Enhances DCA-induced Apoptosis

    Authors: , , , , , , , , , , , , , , , - Molecular Biology of the Cell 2001 cited by 233

  21. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes

    Authors: , , , , , , , - Hepatology 2002 cited by 144

  22. Autocrine regulation of mda -7/IL-24 mediates cancer-specific apoptosis

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 121

  23. Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , - American Journal of Clinical Oncology 2019 cited by 41

  24. Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

    Authors: , , , , , , , , , - Cancer Research 2008 cited by 274